Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Risteli

Showing results (71-80 of 209) with videos related to

Pageof 21
Sort By:
The British Journal of Dermatology|November 1, 1994
Systemic glucocorticoids decrease the synthesis of type I and type III collagen in human skin in vivo, whereas isotretinoin treatment has little effectP Autio, A Oikarinen, J Melkko, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 24, 2001
Familial high serum PICP: high even in skin interstitial fluid, suppressible by topical corticosteroid treatmentA Sorva, R Sorva, J Risteli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Type I and III collagen metabolites as predictors of clinical outcome in epithelial ovarian cancerM Santala, M Simojoki, J Risteli, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 9, 1991
Aminoterminal propeptide of type III procollagen in cerebrospinal fluid. Variation with age and in childhood leukemiaL Vainionpää, L Risteli, M Lanning, et al.
The Journal of Pathology|April 22, 1999
Aberrant type I and type III collagen gene expression in human breast cancer in vivoS Kauppila, F Stenbäck, J Risteli, et al.
The Journal of Experimental Medicine|February 1, 1994
Clearance of NH2-terminal propeptides of types I and III procollagen is a physiological function of the scavenger receptor in liver endothelial cellsJ Melkko, T Hellevik, L Risteli, et al.
Acta Orthopaedica Scandinavica. Supplementum|October 1, 1995
Collagen propeptides as indicators of collagen assemblyJ Risteli, S Niemi, S Kauppila, et al.
Clinical Chemistry|April 1, 1993
Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradationJ Risteli, I Elomaa, S Niemi, et al.
The Journal of Rheumatology|September 1, 1994
Increased type I collagen degradation in early rheumatoid arthritisA Kotaniemi, H Isomäki, M Hakala, et al.
Obstetrics and Gynecology|April 1, 1991
Use of various epithelial tumor markers and a stromal marker in the assessment of cervical carcinomaC Tomás, J Risteli, L Risteli, et al.
Pageof 21

Showing results (71-80 of 209) with videos related to

Sort By:
Pageof 21
The British Journal of Dermatology|November 1, 1994
Systemic glucocorticoids decrease the synthesis of type I and type III collagen in human skin in vivo, whereas isotretinoin treatment has little effectP Autio, A Oikarinen, J Melkko, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 24, 2001
Familial high serum PICP: high even in skin interstitial fluid, suppressible by topical corticosteroid treatmentA Sorva, R Sorva, J Risteli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Type I and III collagen metabolites as predictors of clinical outcome in epithelial ovarian cancerM Santala, M Simojoki, J Risteli, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 9, 1991
Aminoterminal propeptide of type III procollagen in cerebrospinal fluid. Variation with age and in childhood leukemiaL Vainionpää, L Risteli, M Lanning, et al.
The Journal of Pathology|April 22, 1999
Aberrant type I and type III collagen gene expression in human breast cancer in vivoS Kauppila, F Stenbäck, J Risteli, et al.
The Journal of Experimental Medicine|February 1, 1994
Clearance of NH2-terminal propeptides of types I and III procollagen is a physiological function of the scavenger receptor in liver endothelial cellsJ Melkko, T Hellevik, L Risteli, et al.
Acta Orthopaedica Scandinavica. Supplementum|October 1, 1995
Collagen propeptides as indicators of collagen assemblyJ Risteli, S Niemi, S Kauppila, et al.
Clinical Chemistry|April 1, 1993
Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradationJ Risteli, I Elomaa, S Niemi, et al.
The Journal of Rheumatology|September 1, 1994
Increased type I collagen degradation in early rheumatoid arthritisA Kotaniemi, H Isomäki, M Hakala, et al.
Obstetrics and Gynecology|April 1, 1991
Use of various epithelial tumor markers and a stromal marker in the assessment of cervical carcinomaC Tomás, J Risteli, L Risteli, et al.
Pageof 21